The most interesting thing about PatientPoint is also the easiest to miss. You have probably stood inside its product without knowing it. A television murmuring in a waiting room. A touchscreen beside an exam table. A short animation that turns a knot of anatomy into something a nervous patient can finally point at. PatientPoint built a business around those small, captive minutes before a healthcare decision.
It is a digital health company, yes, but that label hides the machinery. PatientPoint operates a sponsor-supported media network inside physician offices. Practices receive screens, communication software and medically reviewed education at no or low cost. Pharmaceutical, medical-device, consumer-health and wellness brands buy targeted exposure. Patients get information near the moment they can ask a clinician what it means.
The scale turns a clever arrangement into infrastructure. PatientPoint reports roughly 30,000 to 32,000 offices, 125,000 healthcare providers and 169,000 connected devices across more than 14 specialties. Its network touches about 750 million patient visits a year. In most prescription categories, the company says one in three prescriptions is written by a PatientPoint provider. The scarce asset is not the rectangle on the wall. It is the context around it.
A P&G lesson walks into a doctor’s office
Mike Collette started the company that became PatientPoint in 1987. At Procter & Gamble, he had watched marketers experiment with “aperture marketing” - reaching someone in the place and instant when a message might matter most. Early place-based media vendors, he later recalled, charged steep prices and offered doubtful measurement. His reaction was blunt: “We could do it a lot better.”
Doing it better was not initially glamorous. Collette cashed in a life-insurance policy, maxed out a credit card and worked on the venture while keeping his day job. The first program put Pampers messaging in hospital maternity wards. Another put Metamucil in gastroenterology offices. These were almost comically literal matches of product to place, but they contained the whole thesis: relevance rises when location does part of the targeting.
PatientPoint did not invent waiting. It made the wait useful, then sold the right to be useful beside it.YesPress analysis
The original medium was pre-digital content shown on waiting-room televisions. Over time, the company moved deeper into the visit. Waiting-room screens prepare patients and carry practice announcements. Exam-room devices offer interactive 3D anatomy, procedure videos and education that can be sent home by email or QR code. Back-office screens help practices reach staff without calling another meeting. Pre- and post-visit products extend the conversation through check-in and patient portals.
Three customers, one suspiciously tidy deal
PatientPoint is a three-sided business in a sector where one unhappy side can ruin the arrangement. Providers need tools that do not slow down care. Patients need understandable information, not a commercial ambush. Sponsors need proof that their campaigns ran before the right audience and influenced something beyond impressions.
The model explains how PatientPoint differs from a conventional patient-engagement SaaS vendor. The practice is an important customer and distribution partner, but it is not always the economic buyer. The sponsor pays because the environment is difficult to reproduce on the open web: health intent is obvious, the audience is close to a professional conversation, and the inventory is physically controlled.
Phreesia is perhaps the clearest alternative. It reaches patients through digital check-in and intake, before, during and after appointments. CheckedUp and Health Monitor compete around in-office screens and education. Patient portals, EHR messaging and ordinary digital advertising compete for pieces of the same budget. PatientPoint’s distinction is the breadth of its installed footprint and its ability to surround a visit, from waiting room to exam room to staff area, with one content and measurement system.
The first thing to fail was faith in the numbers
Point-of-care advertising has an obvious credibility problem. A marketer can count a video play, but was the office open? Was the physician actually at that location? Did an eligible patient see the message? Early place-based media was expensive and hard to verify. The industry could not graduate from niche spending without better evidence.
PatientPoint’s response was operational rather than poetic. It spent four years pursuing Media Rating Council accreditation, including more than 1,000 in-person audits and verification work across its locations. In January 2024, its Digital Campaign Report became the first point-of-care publisher report accredited by the MRC. The dashboard covers ad plays, network uptime and provider and location reach. It is not proof that every campaign improves health, but it is independent confirmation that the delivery metrics follow an audited method.
For outcomes, the company points to matched claims analyses. Its published provider materials associate participating programs with increases of 45% in mammograms, 28% in flu vaccinations and 20% in colon-cancer screenings. Those figures come from specific measured programs, not universal guarantees. That distinction matters. A well-placed message can remove a comprehension or awareness barrier; it cannot fix a lack of clinicians, appointment supply, insurance coverage or patient access.
The screen was the moat - and the ceiling
The office network made PatientPoint valuable, but it also boxed the company into the appointment. The team behind PatientPoint Precision asked the question that changed the product: what about the important moments before, after and between visits? Precision launched in beta in October 2024 to deliver consent-based education and sponsored content around check-in, EHR and portal interactions. The company says about 230 practices joined the beta, another 400 signed in a single week and patient opt-in reached 98%.
In March 2026, PatientPoint pushed the advertising side further. Health Audiences opened waiting-room inventory to programmatic buying. Third-party claims signals - diagnosis codes, prescription history, age and geography - identify offices likely to contain a relevant audience. Buyers can use a managed service or self-service workflow. The Consumer Health Network, launched the same month, widened the sponsor pool beyond prescription brands to OTC, nutrition, wellness and other consumer-health marketers.
These products make sense only under strict conditions. Patients must give meaningful consent. Data handling has to remain privacy-safe. Practice content must retain clinical credibility, and commercial messages cannot masquerade as a physician’s recommendation. The channel is also better at reaching people already connected to care than those who rarely see a doctor. PatientPoint’s own advantage - the clinical setting - defines who it misses.
The merger that made trust part of the product
Capital accelerated the transformation. PatientPoint raised $140 million in 2017 from Searchlight Capital Partners and Silver Point Capital, with longtime backer L Catterton remaining involved. The money supported product upgrades, digital signage and network growth. In 2021, PatientPoint combined with Outcome Health, the Chicago office-media company whose former leadership had become synonymous with a vast fraud scandal. The deal terms were not disclosed, and the combined company kept the PatientPoint name.
PatientPoint publicly praised Outcome’s replacement leaders for rebuilding client trust. That was more than merger etiquette. The enlarged company inherited valuable distribution and a warning: in healthcare media, verification is not back-office housekeeping. It is part of what the customer buys.
Collette starts On Target Media; Pampers and Metamucil supply the first place-based experiments.
$140 million in growth financing backs the digital network and product expansion.
PatientPoint combines with Outcome Health under the PatientPoint brand.
MRC accreditation arrives; Precision begins moving beyond the office screen.
Health Audiences makes the waiting room programmatic; Jim Lang becomes interim CEO.
A very expensive piece of context
In August 2025, Advent International agreed to acquire PatientPoint from investors led by L Catterton and Littlejohn. The companies did not announce a price; Axios reported more than $1.4 billion. That figure looks strange if PatientPoint is described as a collection of televisions. It looks more intelligible if the company is a healthcare distribution network with connected hardware, software, clinical content, advertiser demand, provider relationships and audited inventory attached.
Leadership has changed while the strategy has held. Founder Mike Collette stepped away from the chair after decades shaping the category. Sean Slovenski became CEO in 2024, then left in April 2026 for a CDC operating role. Board chair and former EVERSANA chief Jim Lang took over as interim CEO. The recent launches suggest the next chapter is less about installing another kind of screen and more about making the existing network easier to buy, target and measure.
PatientPoint’s enduring insight remains disarmingly small: the best media channel may be a real place where a real decision is about to happen. The copyable part is the alignment - useful infrastructure for the host, relevant information for the audience and accountable results for the payer. The uncopyable part took 39 years: persuading tens of thousands of medical offices to let the network into the room.